Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Gynecol Oncol. 2017 Jan 18;144(3):524–530. doi: 10.1016/j.ygyno.2017.01.012

Table 4.

Multivariable analysis of survival in women with uterine adenosarcoma by systematic review (n = 230).

Progression-free survival
Cause-specific survival
Survival
Univariable
Multivariable
Survival
Univariable
Multivariable
Characteristic No 2-yr (%) HR (95%CI) P-value HR (95%CI) P-value 2-yr (%) HR (95%CI) P-value HR (95%CI) P-value
Lymph node metastasis <0.001 <0.001
 No 122 79.6 1 1 86.2 1 1
 Yes 9 0 20.0 (7.83–51.1) 4.72 (0.92–24.2) 0.06 0 27.0 (10.0–72.7) 6.24 (1.17–33.4) 0.03
Sarcomatous overgrowth <0.001 <0.001
 No 68 79.4 1 1 92.9 1 1
 Yes 92 46.8 3.39 (2.07–5.55) 2.88 (0.99–8.40) 0.053 63.2 5.95 (2.93–12.1) 3.02 (0.70–13.1) 0.14
Heterologous elements <0.001 <0.001
 No 119 90.2 1 1 96.1 1 1
 Yes 35 36.8 4.95 (2.74–8.92) 2.08 (0.70–6.12) 0.19 42.0 7.88 (3.97–15.6) 3.63 (0.90–14.6) 0.07
Myometrial invasion <0.001 <0.001
 ≤50% 139 82.4 1 1 87.2 1 1
 >50% 21 36.1 3.07 (1.60–5.88) 1.51 (0.48–4.72) 0.48 50.5 4.27 (2.08–8.76) 1.62 (0.47–5.58) 0.44

A Cox proportional hazard regression model for multivariable analysis adjusted for collected covariates. Significant P-values are emboldened. Abbreviations: 2-yr, 2-year proportion.